DCVAX
Live / Registered — Registered and renewed (as of 05 Apr 2023)
What this means for you
Registered since 15 Oct 2002. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Oct 2032: the §8 & §9 renewal).
Record
- Serial number
- 76029211
- Registration number
- 2636385
- Mark type
- Word mark
- Filed
- 19 Apr 2000
- Published for opposition
- 10 Apr 2001
- Registered
- 15 Oct 2002
- Current term from
- 15 Oct 2022
- Next maintenance filing
- §8 & §9 renewal, due by 15 Oct 2032 (grace period to 15 Apr 2033)
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- Northwest Biotherapeutics, Inc., BETHESDA, MD, US
- Northwest Biotherapeutics, Inc., Bothell, WA, US
- Northwest Biotherapeutics, Inc., Seattle, WA, US
Board proceedings on this mark
- Opposition No. 91123918 — CELL GENESYS, INC. v. NORTHWEST BIOTHERAPEUTICS, INC., filed 10 Aug 2001 (Terminated)
Prosecution history
- 05 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Apr 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 05 Apr 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Sept 2022 — TEAS SECTION 8 & 9 RECEIVED
- 15 Oct 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Apr 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Oct 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Oct 2012 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Oct 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Oct 2012 — TEAS SECTION 8 & 9 RECEIVED
- 10 Aug 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Apr 2009 — ASSIGNED TO PARALEGAL
- 20 Apr 2009 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 20 Apr 2009 — PAPER RECEIVED